References
- Löwa A, Jevtic M, Gorreja F, Hedtrich S. Alternatives to animal testing in basic and preclinical research of atopic dermatitis. Exp Dermatol. 2018;27:476–483.
- Paton DM. Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis. Drugs Today. 2017;53:477–487.
- Cho JM, Davis DMR, Wetter DA, et al. Association between atopic dermatitis and squamous cell carcinoma: a case-control study. Int J Dermatol. 2018;57:313–316.
- Jensen AO, Svaerke C, Körmendiné Farkas D, et al. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977–2006). Am J Clin Dermatol. 2012;13:29–36.
- Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–1183.
- Jeong HJ, Oh HA, Nam SY, et al. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth. Int J Cancer. 2013;132:2492–2501.
- Mooy CM, Luyten GP, de Jong PT, et al. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol. 1995;147:1097–1104.
- Štefaniková A, Klačanová K, Pilchová I, et al. Cyclin-dependent kinase 2 inhibitor SU9516 increases sensitivity of colorectal carcinoma cells Caco-2 but not HT29 to BH3 mimetic ABT-737. Gen Physiol Biophys. 2017;36:539–547.
- Ottina E, Lyberg K, Sochalska M, et al. Knockdown of the antiapoptotic Bcl-2 family member A1/Bfl-1 protects mice from anaphylaxis. J Immunol. 2015;194:1316–1322.
- Nam SY, Han NR, Yoon KW, et al. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), an anticancer agent, exerts an anti-inflammatory effect in activated human mast cells. Inflamm Res. 2017;66:871–879.
- Tian BP, Xia LX, Bao ZQ, et al. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation. J Allergy Clin Immunol. 2017;140:418–430.
- Mason KD, Khaw SL, Rayeroux KC, et al. The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. Leukemia. 2009;23:2034–2041.
- Nam SY, Kang SW, Kim JB, et al. Anti-inflammatory effects of porcine placenta in forced swimming tested fatigue mice and RAW264.7 cells. TANG. 2017;7:e20.
- Jeong HJ, Koo HN, Na HJ, et al. TNF-alpha and IL-6 production by aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine. 2002;18:252–259.
- Han H, Roan F, Ziegler SF. The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines. Immunol Rev. 2017;278:116–130.
- Bitschar K, Wolz C, Krismer B, et al. Keratinocytes as sensors and central players in the immune defense against Staphylococcus aureus in the skin. J Dermatol Sci. 2017;87:215–220.
- Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int. 2012;61:3–17.
- Ziegler SF. Thymic stromal lymphopoietin and allergic disease. J Allergy Clin Immunol. 2012;130:845–852.
- Zhang Z, Hener P, Frossard N, et al. Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci USA. 2009;106:1536–1541.
- Yamashita S, Segawa R, Satou N, et al. Induction of thymic stromal lymphopoietin production by nonanoic acid and exacerbation of allergic inflammation in mice. Allergol Int. 2013;62:463–471.
- Lee JH, Lee YS, Lee EJ, et al. Capsiate inhibits DNFB-induced atopic dermatitis in NC/Nga mice through mast cell and CD4+ T-cell inactivation. J Invest Dermatol. 2015;135:1977–1985.
- Han NR, Oh HA, Nam SY, et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol. 2014;134:2521–2530.
- Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278:162–172.
- Yoou MS, Yoon KW, Choi Y, et al. Cordycepin diminishes thymic stromal lymphopoietin-induced interleukin-13 production. Eur J Pharmacol. 2017;802:1–6.
- Breuckmann F, von Kobyletzki G, Avermaete A, et al. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Photoderm Photoimm Photomed. 2002;18:217–222.
- Ekoff M, Lyberg K, Krajewska M, et al. Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival. PLoS One. 2012;7:e39117.